ArticleScientific reports2025
Advanced multiscale machine learning for nerve conduction velocity analysis.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Machine learning for Charcot-Marie-Tooth disease: toward predictive, personalized neuropathy care.Annals of medicine and surgery (2012) · 2026Article
- Advanced multiscale machine learning for nerve conduction velocity analysis.Scientific reports · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This paper presents an advanced machine learning (ML) framework for precise nerve conduction velocity (NCV) analysis, integrating multiscale signal processing with physiologically-constrained deep learning. Our approach addresses three fundamental limitations of conventional NCV techniques: (1) oversimplified nerve fiber modeling, (2) temperature sensitivity, and (3) static measurement interpretation. The proposed framework combines: (i) entropy-optimized wavelet analysis for adaptive multiscale signal decomposition, (ii) thermodynamically-regularized neural networks incorporating Arrhenius kinetics, and (iii) stochastic progression models for uncertainty-aware longitudinal tracking. Through data extracted from prior studies in this field, rigorously validated across 1842 patients from 28 medical centers, we demonstrate significant improvements: 23.4% enhancement in motor NCV accuracy ([Formula: see text]) and 28.7% for sensory fibers. The framework maintains physiological interpretability while achieving superior performance through: (a) wavelet-optimized resolution scales (2-8 ms for motor, 0.5-2 ms for sensory fibers), (b) temperature compensation accurate to [Formula: see text] across 20-[Formula: see text], and (c) probabilistic progression tracking with 88.9% treatment response prediction accuracy. This work establishes new standards for ML applications in clinical neurophysiology by rigorously combining biophysical first principles with data-driven learning, offering both theoretical advances and immediate clinical utility for neuropathy diagnosis and monitoring.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.